On/Off Switch for Receptor Illuminates Path to MS Drug
By Sharon Kingman
Tuesday, October 22, 2013
LONDON – A promising new strategy for treating multiple sclerosis is under investigation. An international team of researchers reported that they have identified a method of stimulating repair of nerve cells that have lost their protective lipid insulation, a process that occurs in multiple sclerosis. The new approach is radically different from that used in existing therapies, which focus on preventing the damage to nerve cells caused by the immune system. The team patented the finding and researchers are collaborating with a pharmaceutical company to develop candidate therapies.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.